Literature DB >> 35420910

Advances in Recurrent Stroke Prevention: Focus on Antithrombotic Therapies.

Brian Mac Grory1, Shadi Yaghi2, Charlotte Cordonnier3, Luciano A Sposato4, Jose G Romano5, Seemant Chaturvedi6.   

Abstract

The past decade has seen significant advances in stroke prevention. These advances include new antithrombotic agents, new options for dyslipidemia treatment, and novel techniques for surgical stroke prevention. In addition, there is greater recognition of the benefits of multifaceted interventions, including the role of physical activity and dietary modification. Despite these advances, the aging of the population and the high prevalence of key vascular risk factors pose challenges to reducing the burden of stroke. Using a cause-based framework, current approaches to prevention of cardioembolic, cryptogenic, atherosclerotic, and small vessel disease stroke are outlined in this paper. Special emphasis is given to recent trials of antithrombotic agents, including studies that have tested combination treatments and responses according to genetic factors.

Entities:  

Keywords:  atrial fibrillation; endarterectomy, carotid; foramen ovale, patent; randomized controlled trial; stroke

Mesh:

Substances:

Year:  2022        PMID: 35420910      PMCID: PMC9015232          DOI: 10.1161/CIRCRESAHA.121.319947

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   23.213


  132 in total

Review 1.  Effect on platelet function of cilostazol, clopidogrel, and aspirin, each alone or in combination.

Authors:  Anthony J Comerota
Journal:  Atheroscler Suppl       Date:  2005-11-04       Impact factor: 3.235

2.  Clopidogrel with aspirin in acute minor stroke or transient ischemic attack.

Authors:  Yongjun Wang; Yilong Wang; Xingquan Zhao; Liping Liu; David Wang; Chunxue Wang; Chen Wang; Hao Li; Xia Meng; Liying Cui; Jianping Jia; Qiang Dong; Anding Xu; Jinsheng Zeng; Yansheng Li; Zhimin Wang; Haiqin Xia; S Claiborne Johnston
Journal:  N Engl J Med       Date:  2013-06-26       Impact factor: 91.245

Review 3.  Atrial Fibrillation and Mechanisms of Stroke: Time for a New Model.

Authors:  Hooman Kamel; Peter M Okin; Mitchell S V Elkind; Costantino Iadecola
Journal:  Stroke       Date:  2016-01-19       Impact factor: 7.914

4.  Effect of a balloon-expandable intracranial stent vs medical therapy on risk of stroke in patients with symptomatic intracranial stenosis: the VISSIT randomized clinical trial.

Authors:  Osama O Zaidat; Brian-Fred Fitzsimmons; Britton Keith Woodward; Zhigang Wang; Monika Killer-Oberpfalzer; Ajay Wakhloo; Rishi Gupta; Howard Kirshner; J Thomas Megerian; James Lesko; Pamela Pitzer; Jandira Ramos; Alicia C Castonguay; Stanley Barnwell; Wade S Smith; Daryl R Gress
Journal:  JAMA       Date:  2015 Mar 24-31       Impact factor: 56.272

5.  Cilostazol versus aspirin in ischemic stroke with cerebral microbleeds versus prior intracerebral hemorrhage.

Authors:  Hong-Kyun Park; Ji Sung Lee; Bum Joon Kim; Jong-Ho Park; Yong-Jae Kim; Sungwook Yu; Yang-Ha Hwang; Joung-Ho Rha; Sung Hyuk Heo; Seong Hwan Ahn; Woo-Keun Seo; Jong-Moo Park; Ju-Hun Lee; Jee-Hyun Kwon; Sung-Il Sohn; Jin-Man Jung; Sun U Kwon; Keun-Sik Hong
Journal:  Int J Stroke       Date:  2020-07-14       Impact factor: 5.266

6.  Dual antiplatelet therapy in stroke and ICAS: Subgroup analysis of CHANCE.

Authors:  Liping Liu; Ka Sing Lawrence Wong; Xinyi Leng; Yuehua Pu; Yilong Wang; Jing Jing; Xinying Zou; Yuesong Pan; Anxin Wang; Xia Meng; Chunxue Wang; Xingquan Zhao; Yannie Soo; S Claiborne Johnston; Yongjun Wang
Journal:  Neurology       Date:  2015-09-29       Impact factor: 9.910

7.  Aortic Arch Atherosclerosis in Patients With Embolic Stroke of Undetermined Source: An Exploratory Analysis of the NAVIGATE ESUS Trial.

Authors:  George Ntaios; Lesly A Pearce; Elena Meseguer; Matthias Endres; Pierre Amarenco; Serefnur Ozturk; Wilfried Lang; Natan M Bornstein; Carlos A Molina; Jorge Pagola; Hardi Mundl; Scott D Berkowitz; Yan Yun Liu; Souvik Sen; Stuart J Connolly; Robert G Hart
Journal:  Stroke       Date:  2019-09-17       Impact factor: 7.914

Review 8.  Cancer and Embolic Stroke of Undetermined Source.

Authors:  Babak B Navi; Scott E Kasner; Mitchell S V Elkind; Mary Cushman; Oh Young Bang; Lisa M DeAngelis
Journal:  Stroke       Date:  2021-01-28       Impact factor: 7.914

9.  Ischemic Stroke Risk After Acute Coronary Syndrome.

Authors:  Shadi Yaghi; Markeith Pilot; Christopher Song; Christina A Blum; Aleksandra Yakhkind; Brian Silver; Karen L Furie; Mitchell S V Elkind; Dean Sherzai; Ayesha Z Sherzai
Journal:  J Am Heart Assoc       Date:  2016-07-13       Impact factor: 5.501

10.  Incidence, outcome, risk factors, and long-term prognosis of cryptogenic transient ischaemic attack and ischaemic stroke: a population-based study.

Authors:  Linxin Li; Gabriel S Yiin; Olivia C Geraghty; Ursula G Schulz; Wilhelm Kuker; Ziyah Mehta; Peter M Rothwell
Journal:  Lancet Neurol       Date:  2015-07-27       Impact factor: 59.935

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.